Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Post by georgesoreloseon May 30, 2017 8:19pm
143 Views
Post# 26303559

New report released today in Dublin - blood purification

New report released today in Dublin - blood purificationLet's pretend to compete with CTSO's "next generation endotoxin product", but ya never know eh; - )


DUBLINMay 30, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Blood Purification Equipment Market Analysis & Trends - Industry Forecast to 2025" report to their offering.

 

This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. 

With comprehensive market assessment across the major geographies such as North AmericaEuropeAsia PacificMiddle EastLatin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., CanadaMexico, U.K., GermanySpainFranceItalyChinaBrazilSaudi ArabiaSouth Africa, etc. market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope.

Key Topics Covered:

1 Market Outline 
1.1 Research Methodology 
1.2 Market Trends 
1.3 Regulatory Factors 
1.4 Application Analysis 
1.5 Strategic Benchmarking 
1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview 
3.1 Current Trends 
3.1.1 Emergence of new generation sensors, single chip solutions and new generation component 
3.1.2 Better understanding of physiology, anatomy and disease patterns 
3.1.3 Increased number of end stage renal disease (ESRD) patients and diabetes 
3.1.4 Companies are developing approaches to combat sepsis from therapeutics 
3.2 Drivers 
3.3 Constraints 
3.4 Industry Attractiveness

4 Blood Purification Equipment Market, By Type 
4.1 Continuous Blood Purification (CBP) 
4.2 Hemoperfusion (HP) 
4.3 Hemodialysis(HD)

5 Blood Purification Equipment Market, By Application 
5.1 Acute Drug Poisoning  
5.2 Chronic Renal Failure

6 Blood Purification Equipment Market, By Geography

7 Key Player Activities 
7.1 Acquisitions & Mergers 
7.2 Agreements, Partnerships, Collaborations and Joint Ventures 
7.3 Product Launch & Expansions 
7.4 Other Activities

8 Leading Companies 
8.1 Accel Diagnostics LLC 
8.2 Aethlon Medical Inc 
8.3 Cerus Corp Company 
8.4 Circle Biologics, LLC 
8.5 CytoSorbents Corp 
8.6 NxStage Medical Inc 
8.7 Spectral Medical Inc 
8.8 Toray Medical Co Ltd 

8.9 Stellarray, Inc 
8.10 Medtronic

For more information about this report visit https://www.researchandmarkets.com/research/sw9sxp/global_blood

Media Contact:

Laura Wood, Senior Manager 
press@researchandmarkets.com  

For E.S.T Office Hours Call 1-917-300-0470 
For U.S./CAN Toll Free Call 1-800-526-8630 
For GMT Office Hours Call +353-1-416-8900 

U.S. Fax: 646-607-1907 
Fax (outside U.S.): +353-1-481-1716


Bullboard Posts